Go Pro

Arkema (OTCMKTS:ARKAY) Stock Passes Below 50-Day Moving Average - Here's What Happened

Arkema logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Arkema shares fell below their 50-day moving average on Wednesday, with the stock trading as low as $61.75 and last changing hands at $62.50. The move came on light volume of 1,329 shares.
  • Analyst sentiment has weakened in recent reports, with several firms cutting ratings, including Berenberg Bank, Goldman Sachs, and Kepler Capital Markets. MarketBeat says Arkema’s average rating is now “Reduce”.
  • The company beat quarterly expectations in its latest earnings report, posting $1.01 EPS on revenue of $2.57 billion versus analyst estimates of $0.91 EPS and $2.52 billion in revenue. Despite the beat, the stock remains under pressure.
  • Five stocks to consider instead of Arkema.

Arkema SA (OTCMKTS:ARKAY - Get Free Report) shares crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $68.73 and traded as low as $61.75. Arkema shares last traded at $62.50, with a volume of 1,329 shares trading hands.

Analyst Ratings Changes

ARKAY has been the topic of several recent analyst reports. Berenberg Bank lowered shares of Arkema from a "strong-buy" rating to a "hold" rating in a report on Monday, April 20th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Arkema in a research report on Tuesday, June 23rd. The Goldman Sachs Group downgraded shares of Arkema from a "buy" rating to a "neutral" rating in a research note on Monday, June 8th. Zacks Research upgraded shares of Arkema from a "strong sell" rating to a "hold" rating in a report on Monday, May 4th. Finally, Kepler Capital Markets cut shares of Arkema from a "hold" rating to a "strong sell" rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Reduce".

Read Our Latest Analysis on Arkema

Arkema Trading Down 0.7%

The stock has a market capitalization of $4.75 billion, a price-to-earnings ratio of 250.00 and a beta of 0.86. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.64 and a current ratio of 2.25. The firm has a fifty day moving average of $68.73 and a 200-day moving average of $66.82.

Arkema (OTCMKTS:ARKAY - Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The basic materials company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.10. The company had revenue of $2.57 billion for the quarter, compared to analysts' expectations of $2.52 billion. Arkema had a return on equity of 4.06% and a net margin of 0.46%. As a group, equities analysts predict that Arkema SA will post 3.48 earnings per share for the current fiscal year.

About Arkema

(Get Free Report)

Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total's chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.

Arkema's operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arkema Right Now?

Before you consider Arkema, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.

While Arkema currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines